Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 12, 2022 | Post-IPO Equity | $250M | 1 | MSD Capital | — | Detail |
Jul 26, 2020 | Grant | $472M | 1 | Biomedical Advanced Research and Development Authority (BARDA) | — | Detail |
Apr 17, 2020 | Grant | $483M | 1 | Biomedical Advanced Research and Development Authority (BARDA) | — | Detail |
Dec 6, 2018 | IPO | $604M | — | — | — | Detail |
May 3, 2018 | Series H | $125M | 1 | Merck | — | Detail |
Feb 1, 2018 | Series G | $500M | 10 | — | — | Detail |
Sep 7, 2016 | Grant | $8M | 1 | — | — | Detail |
Aug 24, 2016 | Series F | $474M | 1 | AstraZeneca | — | Detail |
Jan 12, 2016 | Grant | $20M | 1 | — | — | Detail |
Jan 5, 2015 | Series E | $450M | 6 | — | — | Detail |
Jan 14, 2014 | Corporate Round | $25M | 1 | Alexion Pharmaceuticals | — | Detail |
Nov 20, 2013 | Series Unknown | $110M | 1 | — | — | Detail |
Oct 2, 2013 | Grant | $24.60M | 1 | DARPA | — | Detail |
Dec 6, 2012 | Series Unknown | $40M | 1 | Flagship Pioneering | — | Detail |